Skip to content

Hyster-Yale Materials Handling, Inc. HY Restructuring Costs And Asset Impairment Charges

Restructuring Costs And Asset Impairment Charges at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$0+100%
ALH
Alliance Laundry Holdings Inc.ALH
$0-100%
Enphase Energy logo
Enphase EnergyENPH
$3.83M+21.0%
Kennametal logo
KennametalKMT
$2.12M-62.2%
Sonoco Products logo
Sonoco ProductsSON
$15.13M+11.4%

Other financials

Income statement

See full
Revenue$795.2M-12.7%
Gross profit$124.8M-29.8%
Operating income-$28.0M-231%
Net income-$30.5M-455%
EPS (diluted)-$1.71-456%

Balance sheet

See full
Cash & equivalents$81.8M+6.0%
Total debt$630.6M+63.6%
Total equity$430.1M-15.7%
Total assets$2.0B-4.7%

Cash flow

See full
Operating cash flow-$32.9M+9.6%
CapEx$9.8M-7.5%
Free cash flow-$42.7M+9.1%

Valuation

See full
Market cap$652.32M-4.3%
Enterprise value$1.2B+21.4%
P/S0.2×0.0×

Profitability

See full
Gross margin15.9%-4.3pp
Operating margin-2%-6.3pp
Net margin-2.7%-5.1pp
FCF margin3%

Returns & leverage

See full
Return on equity-21.1%-42.7pp
Debt / equity1.5×+0.7×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Hyster-Yale Materials Handling, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCostsAndAssetImpairmentCharges.

The official record: Hyster-Yale Materials Handling, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hyster-Yale Materials Handling, Inc.'s restructuring costs and asset impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hyster-Yale Materials Handling, Inc.'s restructuring costs and asset impairment charges?
Hyster-Yale Materials Handling, Inc. (HY) reported restructuring costs and asset impairment charges of $9.6M in Q4 2025.
What does restructuring costs and asset impairment charges mean?
This metric represents the total expenses recognized in the income statement related to organizational restructuring initiatives and the write-down of long-lived assets. It reflects management's efforts to streamline operations or adjust the asset base to align with current market conditions. Investors monitor this to assess the impact of non-recurring strategic shifts on short-term profitability.